The Rehabilitation Effect of Exercise Training in Cruciate Ligament Reconstruction Patients.
NCT ID: NCT03359382
Last Updated: 2017-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2017-11-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Physical Therapy and/or Platelet Rich Plasma Injection in People With Knee Cruciate Ligament Injuries
NCT06233305
Neuromuscular Rehab for ACL Reconstruction: Knee Function & Brain Plasticity
NCT07243860
Prolonged Preoperative Rehabilitation in ACL Rupture.
NCT04888052
The Effect of Single-leg 20-degree Squats Combined With Conventional Training on the Biomechanical Characteristics of Gait After Anterior Cruciate Ligament Reconstruction Surgery
NCT07308431
Effects of Preoperative Rehabilitation on Tendon Healing, Bone Mineral Density, and Cartilage After ACLR and Patellar Dislocation
NCT05924178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
No interventions assigned to this group
exercise
Resistance or home exercise combined with eccentric exercise
First year: Progressive resistance exercise (60-80% RM) combined with low intensity eccentric exercise (10%RM).
Second year: Progressive resistance exercise (60-80% RM) combined with progressive eccentric exercise (10-80% RM).
Third year:Home exercise combined with low intensity eccentric exercise (10% RM )
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance or home exercise combined with eccentric exercise
First year: Progressive resistance exercise (60-80% RM) combined with low intensity eccentric exercise (10%RM).
Second year: Progressive resistance exercise (60-80% RM) combined with progressive eccentric exercise (10-80% RM).
Third year:Home exercise combined with low intensity eccentric exercise (10% RM )
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wei-Hsiu Hsu
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei-Hsiu Hsu, Dr.
Role: STUDY_CHAIR
Sports Medicine Center, Chang Gung Memorial Hospital at Chia Yi, Chia Yi, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sports Medicine Center, Chang Gung Memorial Hospital
Chiayi City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CORPG6G0271-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.